Sintx Technologies, Inc.
SINTX Technologies is a U.S.-based advanced ceramics company focused on silicon nitride materials and components for biomedical and other technical applications. Its business combines materials research, manufacturing, and commercialization of ceramic products used in medical devices, with additional activity in coatings, aerospace-related materials, toll processing, and government-funded work.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueMedical-grade ceramic materials and components used in implant and device applications.
Advanced ceramic coatings, materials, and related components for aerospace uses.
Contract processing and manufacturing work performed for third-party customers.
Revenue tied to government-funded research, development, and contract work.
Products
Reported · share of revenue- Products71.6 %
- Grant and Contract28.4 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
SINTX sells to medical device customers, industrial and aerospace customers, and government counterparties that fund research or contract work. In biomedical markets, buyers are typically device manufacturers seeking ceramic materials with biocompatibility, wear resistance, and antibacterial properties. In non-medical markets, customers use the company’s advanced ceramics capabilities for specialized coatings, components, and processing services.
Buy silicon nitride materials and components for implant and fusion-device applications because of biocompatibility and wear properties.
Buy coatings, materials, and components for technical applications where ceramic performance matters.
Fund contract and grant work tied to research, development, and technical programs.
Use toll processing and manufacturing support to access advanced ceramic capabilities without building them in-house.
Strategy
SINTX’s strategy is to leverage its silicon nitride and advanced ceramics expertise across biomedical, aerospace, and other technical markets. The company is focused on expanding third-party manufacturing opportunities, developing new products, and using research and validation work to broaden commercial adoption of its materials platform.
Broader adoption increases the addressable market for the company’s core material platform.
These relationships can convert technical capability into recurring product and service revenue.
Diversification can reduce dependence on a single end market and expand customer reach.
Geography
SINTX is headquartered in the United States and serves customers across multiple regions through its biomedical and technical ceramics activities. Its spinal implant materials have been used in humans in the U.S., Europe, South America, and Asia, indicating an international end-market footprint even though the company’s operating base is U.S.-centric. Geography matters because medical device adoption, regulatory pathways, and customer qualification cycles differ by region.
Risks
SINTX faces the typical risks of a development-stage materials company, including dependence on customer adoption, regulatory and validation timelines, and the need for continued funding. Its business also carries concentration risk in a small number of product and contract categories, while technical performance, manufacturing scale-up, and reimbursement or qualification hurdles can delay commercialization.
The company states it will require substantial future capital to fund development and commercialization.
Exposure: Operating runway and product development
Revenue depends on customers qualifying and adopting silicon nitride and related products.
Exposure: Medical device and aerospace sales
Biomedical products must clear technical, clinical, and regulatory hurdles before broad use.
Exposure: Implant and fusion-device applications
Grant and contract revenue can fluctuate materially with award timing and project disposition.
Exposure: Government-funded work and contract revenue
Accounting
Judgemental itemsProduct revenue is recognized when control transfers, so shipment timing can shift quarterly results.
Impact: Quarterly revenue comparability
Government awards can be episodic and depend on project milestones or dispositions.
Impact: Revenue volatility
Fair value changes in derivative instruments can create non-cash gains or losses.
Impact: Net income volatility
Small-scale operations increase the importance of testing assets and receivables for recoverability.
Impact: Balance sheet and earnings estimates
Similar listed companies
Publicly listed companies with a comparable business focus.
Silexion Therapeutics Corp
SLXNW · Biological Products, (No Diagnostic Substances)
Silexion Therapeutics Corp is a U.S.-listed holding company whose operations are conducted primarily through its subsidiary Silexion, a clinical-stage…
Syntec Optics Holdings, Inc
OPTXW · Optical Instruments & Lenses
Tronox Holdings plc
TROX · Industrial Inorganic Chemicals
Tronox Holdings plc is a U.S.-listed, England-and-Wales incorporated industrial chemicals company built around titanium dioxide (TiO2) pigment and the mineral-sand supply chain that feeds it.
SIGA Technologies Inc
SIGA · Pharmaceutical Preparations
SIGA Technologies is a U.S.-based pharmaceutical company focused on developing and commercializing treatments for orthopoxvirus infections, centered on its…
SinterCast
SINT · Industrials
SinterCast is a global leader in providing process control technology for the production of Compacted Graphite Iron (CGI), a material known for its strength and durability.
Standex International Corporation
SXI · Refrigeration & Service Industry Machinery
Standex International is a U.S.-based diversified industrial manufacturer organized around five reportable segments: Electronics, Engineering Technologies,…
Last updated: 24/09/2026